Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

MetricMRKMerck & Co.JNJJohnson & JohnsonPFEPfizer
Snapshot
Price$120.60$241.00$24.04
Market cap$295.39B$575.52B$140.89B
Valuation
P/E33x27.4x18.8x
Forward P/E47.1x28.5x19.8x
Growth
Revenue growth2.9%7.9%1.4%
EPS growth-48.3%-3.9%-5.3%
Profitability
Net margin13.6%21.8%11.8%
ROE17.9%26.3%8.4%
Balance sheet & cash
Debt / equity0.94x0.59x0.75x
Free cash flow yield2.9%3.2%11.2%
Dividend yield3.0%2.3%6.6%
Verdict
Investment ratingWeak· 40Neutral· 56Neutral· 48

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearMRKtoday $121JNJtoday $241PFEtoday $24
2027$92.26 – $135.31+12% CAGR$184.37 – $270.40+12% CAGR$18.39 – $26.97+12% CAGR
2028$94.10 – $138.02+7% CAGR$188.05 – $275.81+7% CAGR$18.76 – $27.51+7% CAGR
2029$95.99 – $140.78+5% CAGR$191.81 – $281.33+5% CAGR$19.13 – $28.06+5% CAGR
2030$97.91 – $143.60+4% CAGR$195.65 – $286.95+4% CAGR$19.52 – $28.62+4% CAGR
2031$99.86 – $146.47+4% CAGR$199.56 – $292.69+4% CAGR$19.91 – $29.20+4% CAGR
5-yr CAGR-3.7% – 4.0%-3.7% – 4.0%-3.7% – 4.0%